Aprea logo 445pt.png
Aprea Therapeutics Announces Phase 1/2 Trial of Eprenetapopt + Venetoclax + Azacitidine in TP53 Mutant AML Meets Complete Remission Primary Efficacy Endpoint
June 16, 2021 08:00 ET | Aprea Therapeutics
37% CR rate in 30 efficacy-evaluable patients BOSTON, June 16, 2021 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and...
logo.jpg
BITPOINT LATAM Partners with Acuant to Streamline Crypto Exchange User Experience
June 08, 2021 07:00 ET | Acuant
LOS ANGELES, June 08, 2021 (GLOBE NEWSWIRE) -- Acuant, the globally trusted leading identity platform for fraud prevention and AML compliance, today announced an expanded partnership with BITPOINT...
Acuant Strengthens Anti-Money Laundering and Cryptocurrency Compliance Solutions with Blockchain Analysis Leader Chainalysis
May 11, 2021 07:00 ET | Acuant
LOS ANGELES, May 11, 2021 (GLOBE NEWSWIRE) -- Acuant, the global trusted identity platform for fraud prevention and AML compliance, today announced its partnership with Chainalysis, the blockchain...
ACAMS Logo_TM_RGB.png
ACAMS’ ‘Virtual Europe’ Conference Offers Roadmap on Financial Crime Fight with Guidance from More than 80 Leading Compliance Experts LONDON, May 11, 2021 (GLOBE NEWSWIRE) -- As part of its ongoing effort to facilitate dialogue between private-sector compliance professionals and policy makers , ACAMS will host a three-day training...
PRPO logo.png
Precipio Launches New HemeScreen Panel for AML, with an unparalleled 4-hour turnaround-time
May 10, 2021 10:30 ET | Precipio, Inc.
NEW HAVEN, Conn., May 10, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it has launched a new, four-hour Acute Myeloid Leukemia (AML)...
Intellia.jpg
Intellia Therapeutics Announces First Quarter 2021 Financial Results
May 06, 2021 07:30 ET | Intellia Therapeutics, Inc.
Plan to report initial safety and activity data from Phase 1 study of NTLA-2001, a potentially curative single-dose therapy for transthyretin amyloidosis (ATTR), in mid-2021 On track to submit an IND...
TIP_link_300x300.jpg
Anti-Money Laundering Software Market Growth Sturdy at 21.1% CAGR to Outstrip $4,993.2 Million by 2027 - COVID-19 Impact and Global Analysis by TheInsightPartners.com
April 27, 2021 07:00 ET | The Insight Partners
Pune, India., April 27, 2021 (GLOBE NEWSWIRE) -- Anti-Money Laundering Software Market: Key Insights According to our new research study on “Anti-Money Laundering Software Market to 2027 – Global...
ACAMS’ 12th Annual AML & Anti-Financial Crime Conference – APAC Takes Cutting-Edge Look at the Perils and Promise of Compliance Efforts in the Asia Pacific Region Hong Kong / Singapore, April 20, 2021 (GLOBE NEWSWIRE) -- As part of its ongoing effort to help compliance professionals meet evolving regulatory expectations in the Asia Pacific region, ACAMS will...
logo.jpg
Mexico’s Leading Neobank albo Partners with Acuant to Tackle AML/KYC Compliance
March 23, 2021 07:00 ET | Acuant
LOS ANGELES, March 23, 2021 (GLOBE NEWSWIRE) -- Acuant, a leading global provider of identity verification solutions, today announced a partnership with albo, Mexico’s leading Neobank, which has...
Acuant and Scalable Solutions Partner to Streamline AML/KYC Compliance
March 09, 2021 07:00 ET | Acuant
LOS ANGELES, March 09, 2021 (GLOBE NEWSWIRE) -- Acuant, a leading global provider of identity verification solutions, and Scalable Solutions, a white label digital asset exchange provider, today...